SUDARSHAN JAIN
Pill for China plus one
Indian pharma CEOs met senior officials in FDA and other key agencies to start a conversation. Even if a little late, given the looming presidential election, the proposal deserves attention. The basic idea is to capitalise on India's expertise and infra for manufacturing through financial incentives, tech sharing, collaborative research and tech transfers to expand production in both countries. Pursue onshoring in America and friendshoring in India to reduce dependence on China. And aggregate US, Indian and European demand for certain drugs, as IPA secretary general Sudarshan Jain told me.
Pharmaceutical bodies welcome uniform marketing code
"We welcome the UCPMP. It is a balanced order that ensures that there is a healthy and ethical engagement between the pharmaceutical industry and medical professionals," Indian Drug Manufacturers' Association (IDMA) national president Viranchi Shah said. "It also brings clarity in the domain and has been updated as per current industry practices. The IDMA has always been in favour of ethical marketing practices for its members."
Congress Lok Sabha candidate list: Rahul Gandhi from Amethi, Priyanka from Raebareli? Here is the list that's going viral
Congress leader Rahul Gandhi will contest the Lok Sabha election from Amethi, a constituency he has represented since 2002. The official announcement is imminent, according to Uttar Pradesh Congress leader Pradeep Singhal. Gandhi held the Amethi seat from 2002 to 2019 and was defeated in the 2019 election by BJP's Smriti Irani. He is currently an MP from Wayanad, Kerala.
Wake up, poor sleepers: Uncovering the real causes behind insomnia and avoiding quick fixes
Sleep struggles in the startup ecosystem lead to dependency on self-prescribed sleep supplements. Doctors urge long-term behavioural changes for better sleep. Exceptions manage to follow the 10-3-2-1-0 method, avoid caffeine, exercise, or have flexible work hours.
Spacetech startup for propulsion systems Spacefields raises first institutional funding
The fresh capital will be used towards development and testing of critical hardware and various subsystems, research and development in energetic materials and to expand the company’s team, founder and CEO Masook told ET.
Budget 2024: Pharma industry seeks incentives for R&D, conducive policies
In the upcoming union budget 2024, the Indian pharmaceutical industry is seeking fiscal incentives to promote research and development (R&D) as it is expected to reach a market size of USD 400-450 billion by 2047. The Indian Pharmaceutical Alliance Secretary General, Sudarshan Jain, emphasized the need for continuous investments in research due to high risk and low success rates. The interim Budget 2024-25 should provide benefits in terms of direct and indirect taxes and facilitate business ease for pharma companies.
- Go To Page 1
Will Budget 2024 reduce 20% TCS for taxpayers, levy TCS on credit card forex payments?
Budget 2024: The industry wants the Finance Ministry to reconsider the decision of applying TCS at such a higher rate of 20%. The rate is exceptionally high and almost punitive to the citizens who need to make foreign payments, say experts. Earlier, TCS used to be applicable at 5% when you cross the threshold of Rs 7 lakh for certain transactions.
Ram Mandir inauguration: Here are 10 bhajans you can listen on this auspicious day
Prime Minister Modi shares a devotional playlist ahead of Ayodhya's Ram Mandir inauguration, fostering unity and inspiration. The carefully curated collection of 62 'bhajans' transcends language barriers, symbolizing a universal appeal to Lord Ram. As India eagerly anticipates the historic event on January 22, the playlist becomes a source of devotion, connecting people from diverse backgrounds. The article also highlights the historical significance of Ayodhya and recalls Mahatma Gandhi's use of a Ram bhajan for communal harmony. Additionally, the top 10 popular Ram bhajans are listed, offering a spiritual journey through timeless melodies.
Adani Group’s $79-billion rally makes a winner of GQG’s Rajiv Jain
Jain’s investment — it came near the trough of the Adani stock meltdown — has been boosted by a rally in this week after the conglomerate’s green energy unit secured a $1.4 bn loan and a Bloomberg News report said US government found shortseller Hindenburg Research’s allegations irrelevant while advancing a $553 loan for Adani Ports and Special Economic Zone Ltd.’s Sri Lanka project.
Poor EHS compliance a latent risk for pharma, chemical companies
"The general level of awareness and compliance related to EHS (Environment Health & Safety) norms in case of manufacturing companies requires drastic improvement and urgent attention" said Nagaraj Krishnan, managing director, Aparajitha Corporate Services, a tech firm providing compliance solutions to over 2000 companies in India.
Congress forms panels for Rajasthan polls, Sukhjinder Randhawa appointed convener of core committee
The Congress party has formed several panels for the upcoming assembly elections in Rajasthan. Sukhjinder Randhawa has been appointed as the convener of the core committee, while C P Joshi will chair the manifesto panel. Govind Ram Meghwal will lead the campaign committee and Harish Choudhary will head the strategic committee.
Buy PNB Housing Finance, target price Rs 535: Jayesh Bhanushali
PNB Housing Finance key Products/Revenue Segments include Interest, Fees & Commission Income, Income From Sale Of Share & Securities for the year ending 31-Mar-2022.
Buy Abbott India, target price Rs 25243 : Sharekhan by BNP Paribas
Abbott India, incorporated in the year 1944, is a Large Cap company (having a market cap of Rs 42545.46 Crore) operating in Pharmaceuticals sector.
Indian pharma sector set for 'volume to value leadership' journey in 2023
While R&D investment, market competitiveness, regulatory scrutiny, and domestic price regulations are expected to shape the growth of generics and injectable products, concerns such as price control and customs duties on medical equipment will continue to bother the healthcare industry in 2023.
Panel for removing penal provisions from proposed Drugs Act for lapses
The existing Drugs and Cosmetics Act, 1940 is prosecutable. Any drug/cosmetic deemed to be adulterated or spurious is punishable with imprisonment and fine too.
Ahead of Market: 12 things that will decide stock action during Muhurat trading
Vinod Nair of Geojit Financial Services said, the market is currently in a stable state and is looking forward to next week’s WPI & Trade data release.
Chemcon, CAMS listing: Should investors buy more, hold or sell?
CAMS, the biggest IPO of FY21, also had a respectable listing pop of 23 per cent, making investors wonder whether there is more money to be made in the stock. Analysts said short-term investors in the two debutants can either make complete exit, or at least partial exit. At the same time, they said that CAMS still has a lot to offer to long-term investors.
Programme code violation by Sudarshan TV, issued show cause notice, Centre tells SC
On September 21, the top court had pondered over the nature and extent of its order regulating 'Bindas Bol' programme on alleged infiltration of Muslims in bureaucracy saying it did not want to 'curtail'? freedom of speech as the programme has 'public interest'? involved on issues of 'foreign funding'? and 'reservation'?.
Prolongation of coronavirus outbreak in China could hit Indian pharma sector
China accounted for 67.56 per cent of total imports of bulk drugs and drug intermediates in 2018-19 at USD 2,405.42 million. "The situation is being closely monitored by all companies. The government is seized of the issue and all are working in an integrated way to deal with the situation." Indian Pharmaceutical Alliance (IPA) Secretary General Sudarshan Jain told PTI.
Indian pharma cos need to focus on innovation & complex generics: Sudarshan Jain
"Open up pharma market, it will be win-win for Indian companies as well as China."
The Daring Six: How India's top fund managers conquered fear and made you richer
Here is the story of how they did it and what their funds' performance means for investors
Cricket ace Yuvraj Singh’s company YouWeCan Ventures invests in Startup Buddy
The cricketer, who launched his venture fund in 2015, will join the board of Startup Buddy, even as he seeks to expand his engagement with startups.
Sensex tanks 514 points, hits 5-month low; Nifty50 cracks below 8,110
The 30-share BSE Sensex plummeted 1.92 per cent to 26,304.63. The headline index hit an intraday high of 26,809 and a low of 26,253.
2017 and 2018 will be good for pharma: Deepak Shenoy, Capital Mind
Adani Ports a momentum play. From here, it is more a trading call than long term story though I think the port story has to evolve a little more
Why you should accept the next job offer from a startup
Startups are fast emerging as exciting new career destinations. They are able to pay top dollar and offer exciting roles.
Lalit Modi controversy: Sushma Swaraj may just be collateral damage in the politics of cricket
Sushma’s political persona was that of a north Indian, Brahmin and wife who reluctantly stepped out to help her elders run the country.
India's HNIs fine-tune the art of giving, coffers of GiveIndia's First Givers Club swells
The FGC announced it had channelled about 23 crore for various charitable works since its inception in 2010 - more than half of it in 2012-13 alone.
Indians as global CEOs continuing story; Pandit case one-off: Experts
Exit of Vikram Pandit as chief of Citigroup may have come as a big surprise, but experts are convinced that it is a one-off case.
'BUY' OR 'SELL' ideas by experts for closing trade
Indian shares were trading lower in choppy trade on Wednesday. ET Now spoke to various analysts and here's what they have to recommend for closing trade:
Load More
